Literature DB >> 12391227

Structural factors contributing to DM susceptibility of MHC class II/peptide complexes.

Michael P Belmares1, Robert Busch, Kai W Wucherpfennig, Harden M McConnell, Elizabeth D Mellins.   

Abstract

Peptide loading of MHC class II (MHCII) molecules is assisted by HLA-DM, which releases invariant chain peptides from newly synthesized MHCII and edits the peptide repertoire. Determinants of susceptibility of peptide/MHCII complexes to DM remain controversial, however. Here we have measured peptide dissociation in the presence and the absence of DM for 36 different complexes of varying intrinsic stability. We found large variations in DM susceptibility for different complexes using either soluble or full-length HLA-DM. The DM effect was significantly less for unstable complexes than for stable ones, although this correlation was modest. Peptide sequence- and allele-dependent interactions along the entire length of the Ag binding groove influenced DM susceptibility. We also observed differences in DM susceptibility during peptide association. Thus, the peptide repertoire displayed to CD4(+) T cells is the result of a mechanistically complicated editing process and cannot be simply predicted from the intrinsic stability of the complexes in the absence of DM.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12391227     DOI: 10.4049/jimmunol.169.9.5109

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Conformational lability in the class II MHC 310 helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchange.

Authors:  Corrie A Painter; Maria P Negroni; Katherine A Kellersberger; Zarixia Zavala-Ruiz; James E Evans; Lawrence J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

2.  DM influences the abundance of major histocompatibility complex class II alleles with low affinity for class II-associated invariant chain peptides via multiple mechanisms.

Authors:  Cornelia H Rinderknecht; Sujin Roh; Achal Pashine; Michael P Belmares; Namrata S Patil; Ning Lu; Phi Truong; Tieying Hou; Claudia Macaubas; Taejin Yoon; Nan Wang; Robert Busch; Elizabeth D Mellins
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

3.  Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides.

Authors:  Zemin Zhou; Eduardo Reyes-Vargas; Hernando Escobar; Brant Rudd; Alan L Rockwood; Julio C Delgado; Xiao He; Peter E Jensen
Journal:  Eur J Immunol       Date:  2016-01-22       Impact factor: 5.532

4.  Cell surface display of functional human MHC class II proteins: yeast display versus insect cell display.

Authors:  Fei Wen; Dhruv K Sethi; Kai W Wucherpfennig; Huimin Zhao
Journal:  Protein Eng Des Sel       Date:  2011-07-13       Impact factor: 1.650

5.  Empty class II major histocompatibility complex created by peptide photolysis establishes the role of DM in peptide association.

Authors:  Gijsbert M Grotenbreg; Melissa J Nicholson; Kevin D Fowler; Kathrin Wilbuer; Leah Octavio; Maxine Yang; Arup K Chakraborty; Hidde L Ploegh; Kai W Wucherpfennig
Journal:  J Biol Chem       Date:  2007-05-24       Impact factor: 5.157

6.  Small molecules that enhance the catalytic efficiency of HLA-DM.

Authors:  Melissa J Nicholson; Babak Moradi; Nilufer P Seth; Xuechao Xing; Gregory D Cuny; Ross L Stein; Kai W Wucherpfennig
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

7.  Structural Insights Into HLA-DM Mediated MHC II Peptide Exchange.

Authors:  Corrie A Painter; Lawrence J Stern
Journal:  Curr Top Biochem Res       Date:  2011

8.  High-level intrinsic disorder explains the universality of CLIP binding to diverse MHC class II variants.

Authors:  Vladimir N Uversky; Yaping N Tu; Onyekachi Nwogu; Shanitra N Butler; Michael Ramsamooj; George Blanck
Journal:  Cell Mol Immunol       Date:  2017-07-31       Impact factor: 11.530

9.  Susceptibility to HLA-DM protein is determined by a dynamic conformation of major histocompatibility complex class II molecule bound with peptide.

Authors:  Liusong Yin; Peter Trenh; Abigail Guce; Marek Wieczorek; Sascha Lange; Jana Sticht; Wei Jiang; Marissa Bylsma; Elizabeth D Mellins; Christian Freund; Lawrence J Stern
Journal:  J Biol Chem       Date:  2014-07-07       Impact factor: 5.157

10.  A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC(50) determination.

Authors:  Liusong Yin; Lawrence J Stern
Journal:  J Immunol Methods       Date:  2014-02-25       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.